Levosimendan and Low Cardiac Output After Cardiac Surgery: Analysis of Trial Data.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Journal of Cardiothoracic and Vascular Anesthesia

• Publication date

  2023-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.jvca.2023.03.011PMID 37028989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors and Associated Clinical Outcomes of Low Cardiac Output Syndrome Following Cardiac Surgery: Insights from the LEVO-CTS Trial.

  2022cited by this paper
• The Effect of Low Preoperative Ejection Fraction on Mortality After Cardiac Surgery in Indonesia

  2022cited by this paper
• Perioperative Risk Factors for Intensive Care Unit Readmissions and Mortality After Cardiac Surgery.

  2021cited by this paper
• Association between cardiopulmonary bypass time and 90-day post-operative mortality in patients undergoing arch replacement with the frozen elephant trunk: a retrospective cohort study

  2019cited by this paper
• Levosimendan use in patients with preoperative low ejection fraction undergoing cardiac surgery: A systematic review with meta-analysis and trial sequential analysis.

  2019cited by this paper
• Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial

  2017cited by this paper
• Low-Cardiac-Output Syndrome After Cardiac Surgery.

  2017cited by this paper
• Validation of the EuroSCORE II in a Greek Cardiac Surgical Population: A Prospective Study

  2017cited by this paper
• Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery

  2017cited by this paper
• Levosimendan for Hemodynamic Support after Cardiac Surgery

  2017cited by this paper
• Outcome of cardiac surgery in patients with low preoperative ejection fraction

  2016cited by this paper
• Predictors of low cardiac output syndrome after isolated coronary artery bypass grafting.

  2015cited by this paper
• Levosimendan improves renal outcome in cardiac surgery: a randomized trial.

  2014cited by this paper
• Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.

  2013cited by this paper
• Levosimendan: current data, clinical use and future development

  2013cited by this paper
• Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: trends over 18 years.

  2012cited by this paper
• Risk factors for low cardiac output syndrome after coronary artery bypass grafting surgery.

  2012cited by this paper
• Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.

  2010cited by this paper
• Predictors of low cardiac output syndrome after isolated mitral valve surgery.

  2010cited by this paper
• Hypothermic circulatory arrest with selective antegrade cerebral perfusion in ascending aortic and aortic arch surgery: a risk factor analysis for adverse outcome in 501 patients.

  2008cited by this paper
• Clinical Characteristics and In-Hospital Outcomes of Patients With Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Insights From the Society of Thoracic Surgeons National Cardiac Database

  2008cited by this paper
• Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery.

  2008cited by this paper
• Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

  2007cited by this paper
• Acute renal failure after isolated CABG surgery: six years of experience.

  2007cited by this paper
• Central nervous system injury associated with cardiac surgery.

  2006cited by this paper
• Predictors of Low Cardiac Output Syndrome After Isolated Aortic Valve Surgery

  2005cited by this paper
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

  2002cited by this paper
• Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources.

  1996cited by this paper

• Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery

  2025cites this paper
• Syndrome de bas débit cardiaque après chirurgie cardiaque adulte

  2025cites this paper
• Effect of preoperative autologous platelet-rich plasmapheresis on postoperative bleeding in patients undergoing heart valve surgery

  2024cites this paper
• Effect of Levosimendan on Low Cardiac Output Syndrome After Pericardiectomy

  2024cites this paper